Breaking News
April 20, 2019 - Diabetes treatment may keep dementia, Alzheimer’s at bay
April 20, 2019 - New bandage-like biosensor collects and analyzes sweat
April 20, 2019 - A comprehensive, centralized database of bovine milk compounds
April 20, 2019 - Two new epigenetic regulators maintain self-renewal of embryonic stem cells
April 20, 2019 - New Evidence That Veggies Beat Steak for Heart Health
April 20, 2019 - Study reveals genes associated with heavy drinking and alcoholism
April 20, 2019 - Texas A&M AgriLife becomes the newest member of NutriRECS international consortium
April 20, 2019 - In most states, insurance won’t cover addiction treatments
April 20, 2019 - Computer-based memory games may be beneficial for individuals with fragile X syndrome
April 20, 2019 - Timing of food intake influences molecular clock in the liver of mice
April 20, 2019 - Precise decoding of breast cancer cells paves way for new treatment option
April 20, 2019 - Scientists use 3D imaging to help model complex processes performed by placenta
April 20, 2019 - MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS
April 20, 2019 - Genetic variants that protect against obesity could aid new weight loss medicines
April 20, 2019 - New technology developed for microscopic imaging in living organisms
April 20, 2019 - when quitting cigarettes, consider using more nicotine, not less
April 20, 2019 - Key proteins can block Listeria without triggering the death of host cells
April 20, 2019 - Researchers create a working model of cerebral tract to study brain function
April 20, 2019 - New study shows that microbes can help break toxic chemical in dust
April 20, 2019 - Scientists use NIR light and injected DNA nanodevice to guide stem cells to injury
April 20, 2019 - Microbial Features ID’d for Pediatric Irritable Bowel Syndrome
April 20, 2019 - Study reveals patterns of drug intoxication deaths, organ donors across the US
April 20, 2019 - Scientists deploy CRISPR gene-editing tool to engineer multiple edits
April 20, 2019 - AHA News: Here’s How Middle-Aged People — Especially Women — Can Avoid a Heart Attack
April 20, 2019 - Charcot foot: MedlinePlus Medical Encyclopedia
April 20, 2019 - France to ban popular breast implants over cancer risk: media
April 20, 2019 - Researchers explore whether time of day can affect the body’s response to physical exertion
April 20, 2019 - CPAP brings longer life for obese people with sleep apnea: Study
April 20, 2019 - New discovery transforms conventional microfluidics into open-space microfluidics
April 20, 2019 - An accurate estimation of the overall cost of bacterial resistance in French hospitals during 2015 and 2016
April 20, 2019 - ‘PRO-cision Medicine’ approach helps personalize care for patients with cancer
April 19, 2019 - TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Marginal Zone Lymphoma
April 19, 2019 - Screen time—even before bed—has little impact on teen well-being: study
April 19, 2019 - Cytosurge’s first FluidFM User Conference
April 19, 2019 - New study finds that previously described differences among endoscopists are not true
April 19, 2019 - Study compares effectiveness and cost of gene therapy and HSCT in major beta-thalassemia
April 19, 2019 - Scientific breakthrough provides new hope for people living with multiple sclerosis
April 19, 2019 - New Virtual Reality Therapy game could offer relief for patients with chronic pain, mobility issues
April 19, 2019 - Emergency medicine doctors find better way to treat severe epileptic seizures in children
April 19, 2019 - MedlinePlus: Cholesterol Good and Bad
April 19, 2019 - For busy medical students, two-hour meditation study may be as beneficial as longer course
April 19, 2019 - Music therapy helps young patients feel better
April 19, 2019 - Molecular target UNC45A is essential for cancer cell proliferation and tumor growth
April 19, 2019 - Crackling and wheezing could be the sounds of a progressing lung disease
April 19, 2019 - Key research takeaways from ECCMID 2019
April 19, 2019 - AI Can Identify Model of Cardiac Rhythm Device From Chest X-Ray
April 19, 2019 - New way to combat childhood anxiety: treat the parents
April 19, 2019 - Women getting C-sections best judge of own pain medication needs | News Center
April 19, 2019 - Light-intensity physical activity associated with healthy brain aging
April 19, 2019 - Immune responses that prevent fungal infections may eliminate Trichinella spiralis
April 19, 2019 - Exercising in the morning, rather than at night, may yield better results, shows study
April 19, 2019 - Why eating ‘right’ could cause you to stray from your diet
April 19, 2019 - Health Tip: Antidepressant Precautions – Drugs.com MedNews
April 19, 2019 - Bigger portions lead to preschoolers eating more over time
April 19, 2019 - Specific strains of Staphylococcus aureus linked to wounds that do not heal
April 19, 2019 - Morning exercise may burn more calories
April 19, 2019 - Nominations invited for prestigious awards at Pittcon Conference & Expo 2020
April 19, 2019 - Revolutionary discovery paves new way for treatment of necrotizing enterocolitis
April 19, 2019 - Drug that treats high blood pressure shows promise against neurodegenerative diseases
April 19, 2019 - More care is needed for patients after kidney transplantations, reports research
April 19, 2019 - Virtual reality offers benefits for Parkinson’s disease patients
April 19, 2019 - Liver Illness Strikes Latino Children Like A ‘Silent Tsunami’
April 19, 2019 - Disruptive behaviors in autistic children linked to reduced brain connectivity
April 19, 2019 - New insights into how vitamin D affects immune system
April 19, 2019 - Microfluidic-based drug screening chip identifies antibiotic interactions in eight hours
April 19, 2019 - Research sheds light on how hepatitis B virus establishes chronic infection
April 19, 2019 - New scoring system based on genetic markers predicts obesity risk at birth
April 19, 2019 - Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older
April 19, 2019 - Exercise can improve non-motor symptoms of Parkinson’s disease
April 19, 2019 - Phasefocus to launch new cell imaging system
April 19, 2019 - KZFPs play a key role in the regulation of human genome
April 19, 2019 - DWK Life Sciences offers Workflow Solutions to improve productivity
April 19, 2019 - Bedfont wins 2nd accolade at the South East FSB Awards 2019
April 19, 2019 - Extracts of ginkgo seeds show antibacterial activity on pathogens that cause skin infections
April 19, 2019 - Groundbreaking experiment in pigs challenges the notion about brain damage
April 19, 2019 - Improving the quality of digital pathology imaging
April 19, 2019 - Scientists get closer to injecting artificial lymph nodes into people to fight disease
April 19, 2019 - Exercises and swimming goggles may reduce adverse effects on eye during long spaceflights
April 19, 2019 - Review suggests a reciprocal relationship between obesity and self-control
April 19, 2019 - Synthetic biologists add analog-to-digital signal processing to genetic circuitry of living cells
The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’

The Brain Institute wins $7.04 million grant to investigate ‘neurophilosphy of free will’

image_pdfDownload PDFimage_print

The newly-minted Institute for Interdisciplinary Brain and Behavioral Science (The Brain Institute) at Chapman University, with Dr. Uri Maoz as project leader, is the recipient of a total of $7.04 million to study how the human brain enables conscious control of decisions and actions. The John Templeton Foundation funded $5.34 million; the Fetzer Institute funded $1.55 million; and the remaining $150,000 comes from the Fetzer Memorial Trust. This is Chapman’s largest non-federal research grant to date. With the Chapman Brain Institute serving as the central hub, this grant supports research efforts at 17 universities spanning four continents, including Charité Berlin (Germany), Dartmouth, Duke, Florida State University, Harvard, Indiana University Bloomington, NIH, Monash University (Australia), NYU, Sigtuna (Sweden), Tel Aviv University (Israel), University College London (UK), University of Edinburgh (UK), UCLA and Yale. The project launched at an international conference on the Neuroscience of Free Will that the Brain Institute and Crean College of Health and Behavioral Sciences at Chapman University hosted in mid-March.

“We were pleased to establish Chapman’s Brain Institute and to bring the faculty associated with it to Chapman University last year,” said Daniele Struppa, Ph.D., Chapman University president. “Their approach to research reflects Chapman’s goal of combining research with teaching and involving undergraduate and graduate students at all levels in the process. We are grateful for this grant from the Templeton Foundation and the Fetzer Institute, which recognizes Chapman as a leader in this developing field.”

“This grant aims to create a new field in the study of the brain–the neurophilosphy of free will,” said Uri Maoz, Ph.D., assistant professor of psychology and computational neuroscience at Chapman University. “The extent and scope of human free will has been debated by philosophers for millennia. In recent decades, neuroscientists have joined the discussion, leading to some interesting discoveries. The current project, however, represents a four-year effort forging structured, close collaborations on these questions between eight neuroscientists (including Dr. Aaron Schurger, assistant professor of psychology, the latest faculty recruit to the Brain Institute at Chapman) and nine philosophers from around the world. Hopefully, in 10 years we will look back at the grant and say that’s where it all started,” said Dr. Maoz.

“This large-scale investment, by the John Templeton Foundation and the Fetzer Institute, comes to the Brain Institute even before its official launch next month,” said Amir Raz, Ph.D., Chapman University professor of psychology and brain sciences and director of the Brain Institute. “Work at the Brain Institute addresses fundamental questions of human experience: do we have free will? Are we, in fact, free to do what we wish? What is the role of consciousness in our decisions? We are grateful for the opportunities the combined grant offers as well as the testament it provides to confidence in our work.”

“The Templeton Foundation and Fetzer Institute grant acknowledge that consequential, complex questions find answers only when approached through the lenses of multiple disciplines and their research techniques,” said Janeen Hill, Ph.D., dean of Crean College. “Chapman University and Crean College’s commitment to brain science and its inherent interdisciplinarity is reinforced by the significance of this combined grant.”

Entitled “Consciousness and Free Will: A Joint Neuroscientific-Philosophical Investigation,” the grant aims to advance efforts in the neurophilosphy of free will. For example, researchers at the Brain Institute and their collaborators will use advanced analysis techniques of brain activity and strive to decode decisions and actions before they take place. Or they will use various techniques to compare human brain activity when people make arbitrary decisions (e.g., when asked to randomly raise their left or right hand) and deliberate ones (e.g., when asked to raise their left or right hand to donate to one charity or another).

“This grant, placing Chapman as a leader in neuroscience, reflects our deepening commitment to research and to academic excellence,” said Glenn Pfeiffer, Ph.D., provost of Chapman University. “This announcement comes soon after the recent elevation of Chapman University to Carnegie Classification R2, signifying ‘high research activity.’ We have never been stronger as a research institution than we are right now.”

“In fact,” said Thomas Piechota, Ph.D., PE, vice president of research, “this is an opportune time to partner with Chapman University. The research being conducted by the Brain Institute and throughout Chapman is exciting and innovative. Our faculty are exemplary researchers and the involvement of students of every level – including first-year undergraduates – is a fundamental part of the personalized education that we offer.”

Hosted at the Rinker Health Science campus in Irvine, as well as on the Orange campus, the Brain Institute comprises a network of interdisciplinary researchers who conduct empirical investigations into the cognitive neuroscience of altered planes of consciousness, neuropsychology, volition, formal models of higher brain functions among other fields. Our work draws on clinical populations, healthy volunteers, and innovations in artificial intelligence, machine learning, and big data.

“Questions about consciousness and free will are of enduring interest in both philosophy and the sciences. This project will feature field-leading researchers on these two topics, using rigorous and collaborative methods to advance our understanding of both of them. It is therefore a perfect fit for the John Templeton Foundation, and we are pleased to support Chapman in this initiative,” said John Churchill, director of philosophy and theology programs at the John Templeton Foundation.

“We are drawn to this work because of its cutting-edge exploration of free will, the breadth of the research effort Chapman University has developed, and the scale of this major funding collaboration with Templeton,” said Mohammed Mohammed, Fetzer Institute program director of research, discovery, and development. “We are excited about this venture into the intersection of philosophy and neuroscience.”

Tagged with:

About author

Related Articles